Christine S Rollier
Overview
Explore the profile of Christine S Rollier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1090
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bodman-Harris O, Rollier C, Iqbal M
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39771998
Outbreaks of avian pathogens such as Newcastle disease virus, avian influenza virus, and salmonella have a major impact on economies and food security worldwide. Some pathogens also pose a significant...
2.
Pagliari S, Dema B, Sanchez-Martinez A, Montalvo Zurbia-Flores G, Rollier C
J Mol Biol
. 2023 Oct;
435(23):168297.
PMID: 37797831
The history of DNA vaccine began as early as the 1960s with the discovery that naked DNA can transfect mammalian cells in vivo. In 1992, the evidence that such transfection...
3.
Belcher T, Rollier C, Dold C, Ross J, MacLennan C
Front Immunol
. 2023 Sep;
14:1248613.
PMID: 37662926
is the causative agent of gonorrhea, a sexually transmitted infection responsible for a major burden of disease with a high global prevalence. Protective immunity to infection is often not observed...
4.
Iro M, Rollier C, Irani S, Sadarangani M, Al-Diwani A, Pollard A, et al.
Encephalitis
. 2023 Jul;
3(1):15-23.
PMID: 37469716
Purpose: Purpose Regulatory T cells (Tregs) have been implicated in the pathogenesis of several autoimmune disorders and used in adoptive cell transfer therapies. Neither have been explored in patients with...
5.
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
Dold C, Marsay L, Wang N, Silva-Reyes L, Clutterbuck E, Paterson G, et al.
Sci Transl Med
. 2023 Jun;
15(701):eade3901.
PMID: 37343082
Adenoviral-vectored vaccines are licensed for prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Ebola virus, but, for bacterial proteins, expression in a eukaryotic cell may affect the antigen's...
6.
Dold C, Zhu H, Silva-Reyes L, Blackwell L, Linder A, Bewley K, et al.
Vaccine
. 2023 Apr;
41(19):3047-3057.
PMID: 37037709
Q fever is a highly infectious zoonosis caused by the Gram-negative bacterium Coxiella burnetii. The worldwide distribution of Q fever suggests a need for vaccines that are more efficacious, affordable,...
7.
Rollier C, Dold C, Blackwell L, Linder A, Silva-Reyes L, Clutterbuck E, et al.
Vaccine
. 2022 Jun;
40(32):4453-4463.
PMID: 35697571
The clinical development of the meningococcal vaccine, 4CMenB, included 2 doses in vaccine-naïve adolescents, which was considered unlikely to be cost-effective for implementation. Theoretically, priming with 4CMenB in early childhood...
8.
Sheerin D, Dold C, Silva-Reyes L, Linder A, Pollard A, Rollier C
Cell Biosci
. 2022 Jun;
12(1):86.
PMID: 35690803
Background: Disease caused by the capsular group B meningococcus (MenB) is the leading cause of infectious death in UK infants. A novel adenovirus-based vaccine encoding the MenB factor H binding...
9.
Chang C, Awanye A, Marsay L, Dold C, Pollard A, Rollier C, et al.
Vaccine
. 2022 May;
40(28):3835-3842.
PMID: 35610106
Meningococcal meningitis is a rare but serious condition affecting mainly children and young adults. Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease,...
10.
Marsay L, Dold C, Paterson G, Yamaguchi Y, Derrick J, Chan H, et al.
J Infect
. 2022 Mar;
84(5):658-667.
PMID: 35245584
Objective: Adenoviral vectored vaccines, with the appropriate gene insert, induce cellular and antibody responses against viruses, parasites and intracellular pathogens such as Mycobacterium tuberculosis. Here we explored their capacity to...